Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Marts 2026

Genmab — Marts 2026

Planlagt Fastgjort Låst Flyttet Genmab
91 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #64

    more than twice the day volume in the close. major risk off before the weekend or does it have something to do with today's option expiration

    1 Reply Last reply
    0
    • R Offline
      R Offline
      Raun
      wrote on sidst redigeret af
      #65

      Huhej hvor det går - 1600 står for fald...

      1 Reply Last reply
      0
      • SolsenS Offline
        SolsenS Offline
        Solsen
        wrote on sidst redigeret af
        #66

        RSI i 27 på adr aktien. Købssignal jf SB 🙂

        1 Reply Last reply
        0
        • R Offline
          R Offline
          Raun
          wrote on sidst redigeret af
          #67

          Håber godt nok han får ret denne gang 🙂

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #68

            looks like we may get some data on Rina-s early april -Rinatabart sesutecan (Rina-S) plus bevacizumab (BEV) for patients (pts) with recurrent ovarian cancer (OC): First disclosure from cohort D2 of the phase 1/2 RAINFOL-01 study
            Monday, April 13, 2026 via https://sgo2026annualmeeting.eventscribe.net/agenda.asp?BCFO=M|P&pfp=Browse by Day&fa=&fb=&fc=&fd=&all=1

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #69

              also - Tisotumab vedotin in combination with carboplatin and pembrolizumab with or without bevacizumab in first-line recurrent or metastatic cervical cancer: first disclosure of arm H from the ENGOT-cx8/GOG-3024/innovaTV 205 study

              1 Reply Last reply
              0
              • P Offline
                P Offline
                ProinvestorNEWS
                wrote on sidst redigeret af
                #70

                Genmabs anbefaling sættes op til "køb" hos Baptista https://proinvestor.com/investornyt/1424224/genmabs-anbefaling-saettes-op-til-kob-hos-baptista

                1 Reply Last reply
                0
                • concilladoC Offline
                  concilladoC Offline
                  concillado
                  wrote on sidst redigeret af
                  #71

                  Så er vi nede i 1500-regi

                  1 Reply Last reply
                  0
                  • StockBullS Offline
                    StockBullS Offline
                    StockBull
                    wrote on sidst redigeret af
                    #72

                    RSI dagkort tæt på de 27 - købt flere i 1592 - GAK under 1800

                    1 Reply Last reply
                    0
                    • B Offline
                      B Offline
                      Bella1
                      wrote on sidst redigeret af
                      #73

                      Jan van de Winkel valgt som bestyrelsesmedlem i Novo!

                      1 Reply Last reply
                      0
                      • J Offline
                        J Offline
                        JKY_VH
                        wrote on sidst redigeret af
                        #74

                        Ikke den store overraskelse. Next stop bestyrelsesformand.

                        1 Reply Last reply
                        0
                        • concilladoC Offline
                          concilladoC Offline
                          concillado
                          wrote on sidst redigeret af
                          #75

                          Next…. 2027: Breakimg: Genmab fusionerer med Novo 😉

                          1 Reply Last reply
                          0
                          • J Offline
                            J Offline
                            JKY_VH
                            wrote on sidst redigeret af
                            #76

                            MW" Genmab (+1,3%, 1693,50) har fået indledt dækning med anbefalingen "outperform" og kursmålet 32 dollar af børshuset Wolfe Research. Der går ti amerikanske ADR-aktier på én aktie i København, og dermed svarer kursmålet til 320 dollar - eller omregnet 2075 kr. "

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #77

                              Truist upgraded Genmab to “strong-buy” this week, from its prior Buy stance, according to a March 26 report (Truist had already had Genmab at Buy with a $48 target)

                              1 Reply Last reply
                              0
                              • SolsenS Offline
                                SolsenS Offline
                                Solsen
                                wrote on sidst redigeret af
                                #78

                                Spændende udvikling https://finance.yahoo.com/sectors/healthcare/articles/johnson-johnson-darzalex-daratumumab-becomes-103100883.html

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #79

                                  Xian Deng

                                  UBS
                                  Buy Kr.2,600.00 Reiterated 26/3 2026

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #80

                                    people would pop champagne here just a few years ago on such darzalex news ; today nobody gives a sh** lol

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #81

                                      'From a development perspective, the partnership between Janssen Biotech and Genmab A/S to commercialize this therapy has resulted in its use by over 748,000 patients globally' https://www.pharmtech.com/view/implications-of-eu-approval-for-j-j-s-self-administered-daratumumab

                                      1 Reply Last reply
                                      0
                                      • S Offline
                                        S Offline
                                        Sukkeralf
                                        wrote on sidst redigeret af
                                        #82

                                        Yes - as Jan have said many times. Darzalex is a once in a lifetime drug. Lets hope one of the three late stage programs develops into something like that (just for Genmab).

                                        1 Reply Last reply
                                        0
                                        • StockBullS Offline
                                          StockBullS Offline
                                          StockBull
                                          wrote on sidst redigeret af
                                          #83

                                          Aktuel situation (pr. 30. marts 2026)
                                          Genmab-aktien handles i øjeblikket omkring 1.700 DKK. RSI(14) er steget moderat siden den 23. marts, hvor den lå på ca. 30,5, og befinder sig nu i området omkring 40–42.Historisk statistik (2010–marts 2026)
                                          Over de seneste ca. 15 år har RSI(14) været under 30,5 i 18 klare episoder. Af disse tilfælde: 12 gange (67 %) nåede RSI over 65 inden for maksimalt 2 måneder (60 handelsdage).
                                          6 gange (33 %) nåede RSI ikke over 65 inden for denne periode.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper